» Authors » Jan-Erik Guelker

Jan-Erik Guelker

Explore the profile of Jan-Erik Guelker including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 43
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Guelker J, Blockhaus C, Kemala E, Ingerfurth K, Kuervers J, Bufe A
Rev Cardiovasc Med . 2024 Jul; 23(7):249. PMID: 39076914
Objective: Recanalization of in-stent chronic total occlusion (IS-CTO) is challenging and has resulted in inconsistent results. The aim of our study was to analyze the influence of the individual coronary...
2.
Wein B, Seleznova Y, Mueller D, Naumann M, Loeser S, Steffen M, et al.
Int J Cardiol Heart Vasc . 2023 Oct; 49:101281. PMID: 37886218
Background: For patients with acute myocardial infarction (AMI), direct coronary angiography (CA) is recommended, while for non-AMI patients, the diagnostic work-up depends on clinical criteria. This analysis provides initial prospective...
3.
Wein B, Seleznova Y, Mueller D, Naumann M, Loeser S, Artmann J, et al.
Int J Cardiol Heart Vasc . 2023 Apr; 46:101203. PMID: 37091914
Background: With 900'000 coronary angiographies (CA) per year, Germany has the highest annual per capita volume in Europe. Until now there are no prospective clinical data on the degree of...
4.
Blockhaus C, Guelker J, Feyen L, Bufe A, Seyfarth M, Shin D
J Interv Card Electrophysiol . 2022 Aug; 66(3):567-575. PMID: 36038739
Background: Pulsed field ablation (PFA) is a new, non-thermal technology in the treatment of atrial fibrillation (AF). Early investigations have shown a promising safety profile with durable pulmonary vein isolation...
5.
Blockhaus C, Guelker J, Feyen L, Bufe A, Seyfarth M, Shin D
J Cardiovasc Dev Dis . 2022 Jun; 9(6). PMID: 35735804
Background: Wearable cardioverter-defibrillators (WCDs) are a well-established tool to bridge the recovery time of left ventricular ejection fraction (LVEF) until the implantation of an implantable cardioverter defibrillator (ICD), as recommended...
6.
Blockhaus C, Waibler H, Guelker J, Klues H, Bufe A, Seyfarth M, et al.
J Arrhythm . 2022 Apr; 38(2):238-244. PMID: 35387133
Introduction: Cryoballoon (CB) guided pulmonary vein isolation (PVI) is an established procedure in the treatment of atrial fibrillation (AF). Transseptal access is an indispensable step during PVI and may be...
7.
Guelker J, Kinoshita Y, Weber-Albers J, Bufe A, Blockhaus C, Mashayekhi K
Int J Cardiol Heart Vasc . 2022 Jan; 38:100942. PMID: 35079620
Background: The new EuroCTO CASTLE Score was validated against the widely adopted Japanese Multicenter CTO Registry (J-CTO) score in predicting technical success in percutaneous coronary intervention (PCI) for coronary chronic...
8.
Guelker J, Kim W, Blumenstein J, Mollmann H, Husser O
Future Cardiol . 2021 Mar; 17(4):713-722. PMID: 33733824
Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of patients with severe aortic stenosis and is now standard of care for high surgical risk patients and a valid alternative...
9.
Guelker J, Blockhaus C, Bufe A, Kroeger K, Kurvers J, Ilousis D, et al.
Cardiol J . 2021 Feb; 30(1):44-50. PMID: 33634842
Background: With the advent of novel recanalization techniques and emerging devices, percutaneous coronary intervention (PCI) has become a promising leading treatment option for patients with chronic total occlusions (CTO). The...
10.
Guelker J, Bansemir L, Ott R, Rock T, Guelker R, Shin D, et al.
J Tehran Heart Cent . 2019 Nov; 14(2):47-52. PMID: 31723345
Percutaneous coronary intervention (PCI) of total chronic coronary occlusions (CTOs) still remains a major challenge in interventional cardiology. There is little knowledge in the literature about differences in CTO-PCI between...